PEP Therapy is a biotech company developing targeted therapies for the treatment of severe diseases, with an initial focus on cancer.
PEP Therapy is a biotech company developing targeted therapies for the treatment of severe diseases, with an initial focus on cancer.
Sygnis is a biotech company developing innovative tools for molecular biology that play key roles in changing the way genomic and proteomic research is done today.
ForteBio is a biotech company developing analytical systems for the real-time analysis of biomolecular interactions in micro-volume sample sizes. ForteBio is a worldwide specialist for protein quantification and characterization of protein-protein interactions, thus providing valuable information on affinity, kinetics, and concentration.